631 related articles for article (PubMed ID: 11343250)
1. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver.
Beuers U; Bilzer M; Chittattu A; Kullak-Ublick GA; Keppler D; Paumgartner G; Dombrowski F
Hepatology; 2001 May; 33(5):1206-16. PubMed ID: 11343250
[TBL] [Abstract][Full Text] [Related]
2. Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver.
Wimmer R; Hohenester S; Pusl T; Denk GU; Rust C; Beuers U
Gut; 2008 Oct; 57(10):1448-54. PubMed ID: 18583398
[TBL] [Abstract][Full Text] [Related]
3. Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets.
Beuers U; Denk GU; Soroka CJ; Wimmer R; Rust C; Paumgartner G; Boyer JL
J Biol Chem; 2003 May; 278(20):17810-8. PubMed ID: 12626520
[TBL] [Abstract][Full Text] [Related]
4. Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver.
Dombrowski F; Stieger B; Beuers U
Lab Invest; 2006 Feb; 86(2):166-74. PubMed ID: 16344857
[TBL] [Abstract][Full Text] [Related]
5. TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKCalpha-ezrin pathway.
Baiocchi L; Tisone G; Russo MA; Longhi C; Palmieri G; Volpe A; Almerighi C; Telesca C; Carbone M; Toti L; De Leonardis F; Angelico M
Transpl Int; 2008 Aug; 21(8):792-800. PubMed ID: 18435680
[TBL] [Abstract][Full Text] [Related]
6. Modulation of protein kinase C by taurolithocholic acid in isolated rat hepatocytes.
Beuers U; Probst I; Soroka C; Boyer JL; Kullak-Ublick GA; Paumgartner G
Hepatology; 1999 Feb; 29(2):477-82. PubMed ID: 9918925
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
Alpini G; Baiocchi L; Glaser S; Ueno Y; Marzioni M; Francis H; Phinizy JL; Angelico M; Lesage G
Hepatology; 2002 May; 35(5):1041-52. PubMed ID: 11981754
[TBL] [Abstract][Full Text] [Related]
8. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
[TBL] [Abstract][Full Text] [Related]
9. Retrieval of the mrp2 gene encoded conjugate export pump from the canalicular membrane contributes to cholestasis induced by tert-butyl hydroperoxide and chloro-dinitrobenzene.
Schmitt M; Kubitz R; Wettstein M; vom Dahl S; Häussinger D
Biol Chem; 2000; 381(5-6):487-95. PubMed ID: 10937881
[TBL] [Abstract][Full Text] [Related]
10. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes.
Beuers U; Throckmorton DC; Anderson MS; Isales CM; Thasler W; Kullak-Ublick GA; Sauter G; Koebe HG; Paumgartner G; Boyer JL
Gastroenterology; 1996 May; 110(5):1553-63. PubMed ID: 8613063
[TBL] [Abstract][Full Text] [Related]
11. Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis.
Beuers U; Nathanson MH; Isales CM; Boyer JL
J Clin Invest; 1993 Dec; 92(6):2984-93. PubMed ID: 8254052
[TBL] [Abstract][Full Text] [Related]
12. Prevention of Mrp2 activity impairment in ethinylestradiol-induced cholestasis by ursodeoxycholate in the rat.
Crocenzi FA; D'Andrea V; Catania VA; Luquita MG; Pellegrino JM; Ochoa JE; Mottino AD; Sánchez Pozzi EJ
Drug Metab Dispos; 2005 Jul; 33(7):888-91. PubMed ID: 15843489
[TBL] [Abstract][Full Text] [Related]
13. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
[TBL] [Abstract][Full Text] [Related]
14. Biliary secretory function in rats chronically intoxicated with aluminum.
Gonzalez MA; Roma MG; Bernal CA; Alvarez Mde L; Carrillo MC
Toxicol Sci; 2004 May; 79(1):189-95. PubMed ID: 14976346
[TBL] [Abstract][Full Text] [Related]
15. Role of mitogen-activated protein kinases in tauroursodeoxycholic acid-induced bile formation in cholestatic rat liver.
Denk GU; Hohenester S; Wimmer R; Böhland C; Rust C; Beuers U
Hepatol Res; 2008 Jul; 38(7):717-26. PubMed ID: 18328068
[TBL] [Abstract][Full Text] [Related]
16. Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin-induced cholestasis.
Rost D; Kartenbeck J; Keppler D
Hepatology; 1999 Mar; 29(3):814-21. PubMed ID: 10051484
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
Paumgartner G; Beuers U
Hepatology; 2002 Sep; 36(3):525-31. PubMed ID: 12198643
[TBL] [Abstract][Full Text] [Related]
18. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate.
Rost D; Herrmann T; Sauer P; Schmidts HL; Stieger B; Meier PJ; Stremmel W; Stiehl A
Hepatology; 2003 Jul; 38(1):187-95. PubMed ID: 12830001
[TBL] [Abstract][Full Text] [Related]
19. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways.
Schoemaker MH; Conde de la Rosa L; Buist-Homan M; Vrenken TE; Havinga R; Poelstra K; Haisma HJ; Jansen PL; Moshage H
Hepatology; 2004 Jun; 39(6):1563-73. PubMed ID: 15185297
[TBL] [Abstract][Full Text] [Related]
20. Tauroursodeoxycholic acid reduces bile acid-induced apoptosis by modulation of AP-1.
Pusl T; Vennegeerts T; Wimmer R; Denk GU; Beuers U; Rust C
Biochem Biophys Res Commun; 2008 Feb; 367(1):208-12. PubMed ID: 18164257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]